MENU
SEEL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Seelos Therapeutics (SEEL) Ownership - Who owns Seelos Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
300 Park Avenue
Phone
+1 646 293-2100
Employees
16
Web
https://www.seelostherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.7M
P/E Ratio
0.01
Total Cash
294K
Projected Growth
N/A
Total Debt
10.16M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.67
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
SEEL
Capitalization
1.7M
P/E Ratio
0.01
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
294K
Total Cash/Share
0.67
Total Debt
10.2M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
N/A
ROE
N/A
Book Value
-28.13M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
0.08
Current Revenue Per Employee
50500.00
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
79.21
Revenue To Assets
N/A
Shares Held By Institutions
N/A
Shares Outstanding - Current
436K
Total Liabilities
30.5M
Total Volume MTD
N/A
Value
-1
Gain YTD
-97.638
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of novel therapeutics
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
300 Park Avenue
Phone
+1 646 293-2100
Employees
16
Web
https://www.seelostherapeutics.com